AtriCure Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
AtriCure Inc. is a medical device company that develops and sells surgical technologies for treating atrial fibrillation, managing the left atrial appendage, and controlling post-operative pain. Its portfolio includes ablation systems, left atrial appendage exclusion devices, cryoablation products, and related surgical instruments used in cardiac, thoracic, and electrophysiology procedures. AtriCure’s products are designed for use by cardiothoracic surgeons, electrophysiologists, and medical centers that perform open, minimally invasive, and hybrid cardiac surgeries. The company serves healthcare providers in the United States and international markets, supporting procedure workflows in hospitals and specialized surgical settings. Founded in 2000 and headquartered in Mason, Ohio, AtriCure focuses on device-based therapies that address important needs in rhythm management and surgical pain control.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Mr. Michael H. Carrel
- Employees
- 1,350
- Headquarters
- Mason, OH, United States
- Website
- www.atricure.com